Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial
M Kaufmann, E Bajetta, L.Y Dirix, L.E Fein, S.E Jones, J Cervek, C Fowst, A Polli, E Di Salle, G Massimini, G PiscitelliVolume:
36
Année:
2000
Langue:
english
DOI:
10.1016/s0959-8049(00)00240-9
Fichier:
PDF, 68 KB
english, 2000